NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
Back to search
Official data from USPTO
NT NOVOTECH BIOTECH'S PARTNER AT EVERY PHASE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/07/2025
Trademark type
Combined
Nice classes
35, 42
Filing date
03/26/2024
Registration date
05/06/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
05/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
03/14/2024
First use in commerce
03/14/2024
Drawing code
5
Owner type
16
Owner location
Charleston, SC
Examiner
GUTTADAURO, JULIE
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized letters NT positioned to the left of the word NOVOTECH. Beneath NOVOTECH are the words "Biotech's Partner at Every Phase".
Holders and representatives
Holders
NOVOTECH HOLDINGS USA LLC
Representatives
Matthew P. Hintz, Esq. Lowenstein Sandler LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business advisory and consultancy services relating to product development; business advisory and consultancy services relating to regulatory compliance; business research services; market research services; all of the aforementioned services being in the fields of pharmaceuticalsbiotechnology and other related industries
Class 42
Scientific research in the nature of conducting clinical trials for others; conducting and managing clinical trialsincluding clinical trials for pharmaceuticalsbiotechnology and other related industries; providing information about the results of clinical trialsincluding clinical trials for pharmaceuticals and biotechnology; scientific research; medical researchscientific research for medical purposes; preparation of statistics for scientific research; preparation of biostatistics for scientific research in the fields of pharmaceuticalsbiotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticalsbiotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research servicesnamely medical monitoring services for research in the fields of pharmaceuticalsbiotechnology and other related industries; quality auditsquality control for others; preparation of reports and applications to regulators relating to aspects of clinical trials; provision and exchange of information and data exchange between scientistsmanufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocols
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2025
PUBO
PUBLISHED FOR OPPOSITION
02/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/26/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2024
GNRT
NON-FINAL ACTION E-MAILED
12/06/2024
CNRT
NON-FINAL ACTION WRITTEN
12/06/2024
DOCK
ASSIGNED TO EXAMINER
10/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/28/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/11/2024
NWAP
NEW APPLICATION ENTERED
03/26/2024
Continuous trademark protection
Get notified about every new filing that threatens NT NOVOTECH BIOTECH'S PARTNER AT EVERY PHASE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.